2023 Nuclear Medicine Radiology Radiopharmaceuticals 
AuntMinnie
APRIL 15, 2024
Total nuclear medicine patient study volumes decreased by 5.7% between 2021 and 2023, with a 10.7% Two-year compound annual growth rates (CAGR) between 2021 and 2023 show an overall average 2.9% Specifically considering cardiovascular nuclear medicine procedures, total procedures have decreased by 7.1%
AuntMinnie
MARCH 7, 2024
In 2023 compared with 2022, the total volume of positron emission tomography (PET) scans increased 10.2% In 2023, the average number of PET scans per fixed PET site (versus mobile PET) increased 6.7% from 1,401 estimated PET scans per system in 2022 to 1,495 in 2023. Davin Korstjens. physicians reading PET scans per site.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
JULY 12, 2024
As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. A shortage of nuclear medicine technologists means a theranostics center may need to limit its patient volume.
UCSF Biomedical Imaging
JUNE 26, 2023
Congratulations to Henry VanBrocklin, PhD, FSNMMI, FSRS, recipient of the 2023 Paul C. Dr. VanBrocklin is a professor in the Department of Radiology and Biomedical Imaging and director of the Radiopharmaceutical Research Program in the Center for Molecular and Functional Imaging at the University of California, San Francisco (UCSF).
AuntMinnie
MARCH 26, 2024
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.
Imaging Technology
JUNE 26, 2023
Mahmood was presented the award by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) at its 2023 Annual Meeting. Award recipients will have initiated, developed, and successfully implemented unique and significant transformative value within the field of nuclear medicine and molecular imaging.
AuntMinnie
APRIL 4, 2024
A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. Hope, vice chair of clinical operations and strategy in the UCSF department of radiology, established the radioligand therapy group at the university. However, few freestanding theranostics centers exist today. Hope added.
Expert insights. Personalized for you.
111 
Let's personalize your content